Aeglea Biotherapeutics Inc. (AGLE)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
OrbiMed Advisors

Samuel Isaly

4,015,524 $31,803 0.29%
2.
Baker Bros. Advisors

Julian Baker And Felix Baker

3,410,106 $27,008 0.11%
3.
Adage Capital Management

Phill Gross And Robert Atchinson

2,948,141 $23,349 -2% 0.04%
4.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

1,712,088 $13,560 -14% 0.39%
5.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

1,577,296 $12,492 -1% 0.27%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.75 165,000 Officer, Director 538,469 2020-04-30 Filing
$6.23 5,282 Officer, Director 353,643 2019-06-14 Filing
$6.17 14,406 Officer, Director 348,361 2019-06-13 Filing
$6.11 12,217 Officer, Director 333,955 2019-06-12 Filing
$6.86 3,809 Officer, Director 321,738 2019-05-22 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.50 5,900 Officer 2,500 2018-09-27 Filing
$9.55 100 Officer 8,400 2018-09-27 Filing
$10.06 19,550 2,175,314 2018-05-11 Filing
$10.13 22,725 2,194,864 2018-05-10 Filing
$10.11 51,230 2,217,589 2018-05-09 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 6,960 $55,123 0%
2. 3,350,312 $26,534 0%
3. 2,700,000 $21,384 1.21%
4. 2,519,334 $19,953 0.02%
5. 2,174,062 $17,219 0%
News See All